• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于体内成像的数学建模技术,增强了对致癌基因成瘾与肿瘤生长关系的理解。

In vivo imaging-based mathematical modeling techniques that enhance the understanding of oncogene addiction in relation to tumor growth.

机构信息

Department of Electrical Engineering, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Comput Math Methods Med. 2013;2013:802512. doi: 10.1155/2013/802512. Epub 2013 Mar 20.

DOI:10.1155/2013/802512
PMID:23573174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3616361/
Abstract

The dependence on the overexpression of a single oncogene constitutes an exploitable weakness for molecular targeted therapy. These drugs can produce dramatic tumor regression by targeting the driving oncogene, but relapse often follows. Understanding the complex interactions of the tumor's multifaceted response to oncogene inactivation is key to tumor regression. It has become clear that a collection of cellular responses lead to regression and that immune-mediated steps are vital to preventing relapse. Our integrative mathematical model includes a variety of cellular response mechanisms of tumors to oncogene inactivation. It allows for correct predictions of the time course of events following oncogene inactivation and their impact on tumor burden. A number of aspects of our mathematical model have proven to be necessary for recapitulating our experimental results. These include a number of heterogeneous tumor cell states since cells following different cellular programs have vastly different fates. Stochastic transitions between these states are necessary to capture the effect of escape from oncogene addiction (i.e., resistance). Finally, delay differential equations were used to accurately model the tumor growth kinetics that we have observed. We use this to model oncogene addiction in MYC-induced lymphoma, osteosarcoma, and hepatocellular carcinoma.

摘要

对单一癌基因的过度表达的依赖构成了分子靶向治疗的一个可利用的弱点。这些药物可以通过靶向驱动癌基因来产生显著的肿瘤消退,但常常会复发。了解肿瘤对癌基因失活的多方面反应的复杂相互作用是肿瘤消退的关键。很明显,一系列细胞反应导致了肿瘤的消退,而免疫介导的步骤对于防止复发至关重要。我们的综合数学模型包括肿瘤对癌基因失活的各种细胞反应机制。它允许对癌基因失活后事件的时间进程及其对肿瘤负担的影响进行正确的预测。我们的数学模型的许多方面已被证明对于重现我们的实验结果是必要的。这些方面包括许多异质的肿瘤细胞状态,因为遵循不同细胞程序的细胞具有截然不同的命运。这些状态之间的随机转换对于捕获逃避癌基因成瘾(即耐药性)的影响是必要的。最后,延迟微分方程被用于准确地模拟我们观察到的肿瘤生长动力学。我们用它来模拟 MYC 诱导的淋巴瘤、骨肉瘤和肝细胞癌中的癌基因成瘾。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/0aa5e66da346/CMMM2013-802512.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/80ed1a254e52/CMMM2013-802512.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/e2e856f6a4b7/CMMM2013-802512.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/3e440b31fffc/CMMM2013-802512.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/8160a4c9ba1f/CMMM2013-802512.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/a97eb60ffd70/CMMM2013-802512.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/6d58e779a925/CMMM2013-802512.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/0aa5e66da346/CMMM2013-802512.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/80ed1a254e52/CMMM2013-802512.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/e2e856f6a4b7/CMMM2013-802512.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/3e440b31fffc/CMMM2013-802512.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/8160a4c9ba1f/CMMM2013-802512.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/a97eb60ffd70/CMMM2013-802512.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/6d58e779a925/CMMM2013-802512.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7213/3616361/0aa5e66da346/CMMM2013-802512.007.jpg

相似文献

1
In vivo imaging-based mathematical modeling techniques that enhance the understanding of oncogene addiction in relation to tumor growth.基于体内成像的数学建模技术,增强了对致癌基因成瘾与肿瘤生长关系的理解。
Comput Math Methods Med. 2013;2013:802512. doi: 10.1155/2013/802512. Epub 2013 Mar 20.
2
Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.肿瘤休眠、致癌基因成瘾、细胞衰老和自我更新程序。
Adv Exp Med Biol. 2013;734:91-107. doi: 10.1007/978-1-4614-1445-2_6.
3
Survival and death signals can predict tumor response to therapy after oncogene inactivation.存活和死亡信号可以预测癌基因失活后肿瘤对治疗的反应。
Sci Transl Med. 2011 Oct 5;3(103):103ra99. doi: 10.1126/scitranslmed.3002018.
4
A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation.治疗性致癌基因失活后肿瘤消退和复发的数学模型。
Sci Rep. 2021 Jan 14;11(1):1341. doi: 10.1038/s41598-020-78947-2.
5
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.CD4(+) T 细胞有助于重塑微环境,这是癌基因失活后持续肿瘤消退所必需的。
Cancer Cell. 2010 Nov 16;18(5):485-98. doi: 10.1016/j.ccr.2010.10.002. Epub 2010 Oct 28.
6
A tumor-immune mathematical model of CD4+ T helper cell dependent tumor regression by oncogene inactivation.一种通过癌基因失活实现CD4 +辅助性T细胞依赖性肿瘤消退的肿瘤免疫数学模型。
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:4529-32. doi: 10.1109/EMBC.2013.6610554.
7
MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.MYC失活通过肿瘤细胞内在机制和宿主依赖机制引发癌基因成瘾。
Genes Cancer. 2010 Jun;1(6):597-604. doi: 10.1177/1947601910377798.
8
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.MYC失活后肿瘤的持续消退需要p53或血小板反应蛋白-1来逆转血管生成开关。
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16266-71. doi: 10.1073/pnas.0608017103. Epub 2006 Oct 20.
9
Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?癌基因成瘾与癌基因遗忘:或许不仅仅是一种不良习惯?
Cancer Res. 2008 May 1;68(9):3081-6; discussion 3086. doi: 10.1158/0008-5472.CAN-07-5832.
10
The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.与c-Myc相互作用的衔接蛋白Bin1激活非半胱天冬酶依赖性细胞死亡程序。
Oncogene. 2000 Sep 28;19(41):4669-84. doi: 10.1038/sj.onc.1203681.

本文引用的文献

1
Conventional and nanotechniques for DNA methylation profiling.常规和纳米技术用于 DNA 甲基化分析。
J Mol Diagn. 2013 Jan;15(1):17-26. doi: 10.1016/j.jmoldx.2012.06.007. Epub 2012 Nov 2.
2
Revisiting the role of T cells in tumor regression.重新审视 T 细胞在肿瘤消退中的作用。
Oncoimmunology. 2012 May 1;1(3):346-350. doi: 10.4161/onci.18800.
3
Survival and death signals can predict tumor response to therapy after oncogene inactivation.存活和死亡信号可以预测癌基因失活后肿瘤对治疗的反应。
Sci Transl Med. 2011 Oct 5;3(103):103ra99. doi: 10.1126/scitranslmed.3002018.
4
Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction.在 MYC 抑制后复发的淋巴瘤继续表现出癌基因成瘾。
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17432-7. doi: 10.1073/pnas.1107303108. Epub 2011 Oct 3.
5
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.CD4(+) T 细胞有助于重塑微环境,这是癌基因失活后持续肿瘤消退所必需的。
Cancer Cell. 2010 Nov 16;18(5):485-98. doi: 10.1016/j.ccr.2010.10.002. Epub 2010 Oct 28.
6
Interactions between the immune system and cancer: a brief review of non-spatial mathematical models.免疫系统与癌症的相互作用:非空间数学模型简述。
Bull Math Biol. 2011 Jan;73(1):2-32. doi: 10.1007/s11538-010-9526-3. Epub 2010 Mar 12.
7
(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation.采用(18)F和(18)FDG正电子发射断层显像(PET)对骨肉瘤进行成像,以无创监测MYC失活后细胞增殖和骨分化的原位变化。
Cancer Biol Ther. 2008 Dec;7(12):1947-51. doi: 10.4161/cbt.7.12.6947. Epub 2008 Dec 7.
8
Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance.基因组和蛋白质组分析揭示了肿瘤维持所需的MYC阈值水平。
Cancer Res. 2008 Jul 1;68(13):5132-42. doi: 10.1158/0008-5472.CAN-07-6192.
9
Thrombospondins in cancer.癌症中的血小板反应蛋白
Cell Mol Life Sci. 2008 Mar;65(5):700-12. doi: 10.1007/s00018-007-7486-z.
10
Models, mechanisms and clinical evidence for cancer dormancy.癌症休眠的模型、机制及临床证据
Nat Rev Cancer. 2007 Nov;7(11):834-46. doi: 10.1038/nrc2256.